Congress mandates pharmacy access to birth control, creates private right to sue
H.R. 4084 — Access to Birth Control Act · Filed by Robin Kelly (D-IL) · 50 cosponsors · Introduced Jun 23, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires pharmacies to dispense FDA-approved contraceptives and related medications without delay, without intimidation or deception, and without refusal based on personal beliefs. Pharmacies must offer referrals or expedited ordering if items are out of stock. The bill creates civil penalties (up to $1,000/day, capped at $100,000 per case) and a private right of action for customers denied service, while carving out exceptions for lack of valid prescription, inability to pay, and professional clinical judgment.
Why we flagged it
The bill's operative mechanism is a duty imposed on pharmacies to dispense contraceptives without delay or discrimination, backed by civil penalties and private litigation rights. It is a public-health access mandate, not a subsidy or deregulation.
What the text implies
- The private right of action creates potential for high-volume litigation against pharmacies; damages are uncapped except for civil penalties, creating asymmetric litigation risk.
- The 'professional clinical judgment' exception is undefined and may become a litigation flashpoint—pharmacists could claim clinical grounds for refusal, forcing courts to define the boundary.
The full analysis lists 5 implications of this text.
Who stands to gain
pharmaceutical manufacturers (increased contraceptive sales volume); generic drug makers (OTC and prescription contraceptive producers)